Conversion of the OmpF Porin into a Device to Gather Amyloids on the E. coli Outer Membrane

Sol Vendrell-Fernández1, Paloma Lozano-Picazo2, Paula Cuadros-Sánchez1

  • 1Department of Microbial Biotechnology, National Centre for Biotechnology (CSIC), c/ Darwin 3, Campus Cantoblanco, 28049 Madrid, Spain.

ACS Synthetic Biology
|December 1, 2021
PubMed

Insights

Researchers engineered Escherichia coli (E. coli) outer membrane porin OmpF to trap amyloidogenic peptides. This innovation could lead to new biosensors and devices for clearing harmful protein amyloids.

Area of Science:

  • Biochemistry
  • Microbiology
  • Materials Science

Background:

  • Protein amyloids are widespread and pose risks due to infectivity and toxicity.
  • Current concerns involve their role in gut microbiota and soil environments.
  • Understanding amyloid interactions is crucial for developing mitigation strategies.

Purpose of the Study:

  • To engineer a novel bacterial system for trapping protein amyloids.
  • To explore the potential of modified outer membrane porins for amyloid detection and clearance.
  • To investigate the mechanism of amyloid-peptide recognition by engineered bacteria.

Main Methods:

  • Insertion of an amyloidogenic peptide sequence from RepA-WH1 into the L5 loop of Escherichia coli OmpF.
  • Expression of the engineered OmpF in E. coli.
  • Demonstration of bacterial cell trapping of free amyloidogenic peptides.
  • Utilizing immobilized prion-like proteins to capture engineered bacteria.
  • Testing the effect of polyphenolic inhibitors on peptide recognition.

Main Results:

  • Engineered E. coli successfully trapped extracellular amyloidogenic peptides on their surface.
  • The modified OmpF facilitated homotypic interactions characteristic of amyloid assembly.
  • Immobilized prion-like proteins could capture bacteria displaying the engineered OmpF.
  • Polyphenolic molecules interfered with the recognition process, validating the amyloid-like interaction.

Conclusions:

  • Synthetic porins can be engineered to interact with specific protein sequences.
  • This approach offers a platform for developing biosensors and clearance devices for pathogenic amyloids.
  • The study highlights a novel strategy for managing amyloid-related threats in various environments.